Cimicoxib: Difference between revisions
Created page with "<div style="float: right;"> thumb|none|400px|This image is provided by the National Library of Medicine.</div> __NOTOC__ {{SI}} {{CMG}} ==Overview==..." |
m Protected "Cimicoxib": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
<div style="float: right;"> | <div style="float: right;"> | ||
[[File:Cimicoxib.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | [[File:Cimicoxib.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Cimicoxib''' ('''UR-8880''' trade name '''Cimalgex''') is a [[non-steroidal anti-inflammatory drug]] (NSAID) used in [[veterinary medicine]] to treat dogs for pain and inflammation associated with [[osteoarthritis]] and for the management of pain and inflammation associated with surgery.<ref>{{cite web | url = http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/veterinary/medicines/000162/vet_med_000230.jsp&mid=WC0b01ac058008d7a8&jsenabled=true | title = European Public Assessment Report: Cimalgex (cimicoxib) | publisher = European Medicines Agency}}</ref> It acts as a [[COX-2 inhibitor]]. | '''Cimicoxib''' ('''UR-8880''' trade name '''Cimalgex''') is a [[non-steroidal anti-inflammatory drug]] (NSAID) used in [[veterinary medicine]] to treat dogs for pain and inflammation associated with [[osteoarthritis]] and for the management of pain and inflammation associated with surgery.<ref>{{cite web | url = http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/veterinary/medicines/000162/vet_med_000230.jsp&mid=WC0b01ac058008d7a8&jsenabled=true | title = European Public Assessment Report: Cimalgex (cimicoxib) | publisher = European Medicines Agency}}</ref> It acts as a [[COX-2 inhibitor]]. | ||
| Line 20: | Line 16: | ||
{{NSAIDs}} | {{NSAIDs}} | ||
[[Category:Non-steroidal anti-inflammatory drugs]] | [[Category:Non-steroidal anti-inflammatory drugs]] | ||
[[Category:Imidazoles]] | [[Category:Imidazoles]] | ||
Latest revision as of 19:08, 18 August 2015
|
WikiDoc Resources for Cimicoxib |
|
Articles |
|---|
|
Most recent articles on Cimicoxib |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Cimicoxib at Clinical Trials.gov Clinical Trials on Cimicoxib at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Cimicoxib
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Cimicoxib Discussion groups on Cimicoxib Directions to Hospitals Treating Cimicoxib Risk calculators and risk factors for Cimicoxib
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Cimicoxib |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cimicoxib (UR-8880 trade name Cimalgex) is a non-steroidal anti-inflammatory drug (NSAID) used in veterinary medicine to treat dogs for pain and inflammation associated with osteoarthritis and for the management of pain and inflammation associated with surgery.[1] It acts as a COX-2 inhibitor.
Synthesis
Reaction of the imine with tosylisocyanate in the presence of potassium carbonate leads to what may be viewed as 2+3 cycloaddition of the nitrogen analogue of a ketene to form the imidazole ring.
References
- ↑ "European Public Assessment Report: Cimalgex (cimicoxib)". European Medicines Agency.
- ↑ Template:Cite doi